Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands.

BACKGROUND & AIMS: In the Netherlands, a selective hepatitis B virus (HBV) vaccination programme started in 2002 for men having sex with men, drug users, commercial sex workers and heterosexuals with frequent partner changes. We assessed the programme's effectiveness to guide policy on HBV...

Full description

Bibliographic Details
Main Authors: Susan Hahné, Robin van Houdt, Femke Koedijk, Marijn van Ballegooijen, Jeroen Cremer, Sylvia Bruisten, Roel Coutinho, Hein Boot
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3726692?pdf=render
_version_ 1811269762743795712
author Susan Hahné
Robin van Houdt
Femke Koedijk
Marijn van Ballegooijen
Jeroen Cremer
Sylvia Bruisten
Roel Coutinho
Hein Boot
author_facet Susan Hahné
Robin van Houdt
Femke Koedijk
Marijn van Ballegooijen
Jeroen Cremer
Sylvia Bruisten
Roel Coutinho
Hein Boot
author_sort Susan Hahné
collection DOAJ
description BACKGROUND & AIMS: In the Netherlands, a selective hepatitis B virus (HBV) vaccination programme started in 2002 for men having sex with men, drug users, commercial sex workers and heterosexuals with frequent partner changes. We assessed the programme's effectiveness to guide policy on HBV prevention. METHODS: We analysed reports of acute HBV infection in the Netherlands between 2004 and 2010 requesting serum from patients for HBV-genome S- and C-region sequencing. We used coalescence analyses to assess genetic diversity of nonimported genotype-A cases over time. RESULTS: 1687 patients with acute HBV infection were reported between 2004 and 2010. The incidence of reported acute HBV infection decreased from 1.8 to 1.2 per 100,000 inhabitants, mostly due to a reduction in the number of cases in men who have sex with men. Men were overrepresented among cases with an unknown route of transmission, especially among genotype A2 cases mainly associated with transmission through male homosexual contact. The genetic diversity of nonimported genotype-A strains obtained from men who have sex with men decreased from 2006 onwards, suggesting HBV incidence in this group decreased. CONCLUSIONS: The selective HBV-vaccination programme for behavioural high-risk groups very likely reduced the incidence of HBV infection in the Netherlands mainly by preventing HBV infections in men who have sex with men. A considerable proportion of cases in men who did not report risk behaviour was probably acquired through homosexual contact. Our findings support continuation of the programme, and adopting similar approaches in other countries where HBV transmission is focused in high-risk adults.
first_indexed 2024-04-12T21:49:02Z
format Article
id doaj.art-c6af2e9fc4bd43e8a1a8b2fa6c4606f7
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T21:49:02Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c6af2e9fc4bd43e8a1a8b2fa6c4606f72022-12-22T03:15:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0187e6786610.1371/journal.pone.0067866Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands.Susan HahnéRobin van HoudtFemke KoedijkMarijn van BallegooijenJeroen CremerSylvia BruistenRoel CoutinhoHein BootBACKGROUND & AIMS: In the Netherlands, a selective hepatitis B virus (HBV) vaccination programme started in 2002 for men having sex with men, drug users, commercial sex workers and heterosexuals with frequent partner changes. We assessed the programme's effectiveness to guide policy on HBV prevention. METHODS: We analysed reports of acute HBV infection in the Netherlands between 2004 and 2010 requesting serum from patients for HBV-genome S- and C-region sequencing. We used coalescence analyses to assess genetic diversity of nonimported genotype-A cases over time. RESULTS: 1687 patients with acute HBV infection were reported between 2004 and 2010. The incidence of reported acute HBV infection decreased from 1.8 to 1.2 per 100,000 inhabitants, mostly due to a reduction in the number of cases in men who have sex with men. Men were overrepresented among cases with an unknown route of transmission, especially among genotype A2 cases mainly associated with transmission through male homosexual contact. The genetic diversity of nonimported genotype-A strains obtained from men who have sex with men decreased from 2006 onwards, suggesting HBV incidence in this group decreased. CONCLUSIONS: The selective HBV-vaccination programme for behavioural high-risk groups very likely reduced the incidence of HBV infection in the Netherlands mainly by preventing HBV infections in men who have sex with men. A considerable proportion of cases in men who did not report risk behaviour was probably acquired through homosexual contact. Our findings support continuation of the programme, and adopting similar approaches in other countries where HBV transmission is focused in high-risk adults.http://europepmc.org/articles/PMC3726692?pdf=render
spellingShingle Susan Hahné
Robin van Houdt
Femke Koedijk
Marijn van Ballegooijen
Jeroen Cremer
Sylvia Bruisten
Roel Coutinho
Hein Boot
Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands.
PLoS ONE
title Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands.
title_full Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands.
title_fullStr Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands.
title_full_unstemmed Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands.
title_short Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands.
title_sort selective hepatitis b virus vaccination has reduced hepatitis b virus transmission in the netherlands
url http://europepmc.org/articles/PMC3726692?pdf=render
work_keys_str_mv AT susanhahne selectivehepatitisbvirusvaccinationhasreducedhepatitisbvirustransmissioninthenetherlands
AT robinvanhoudt selectivehepatitisbvirusvaccinationhasreducedhepatitisbvirustransmissioninthenetherlands
AT femkekoedijk selectivehepatitisbvirusvaccinationhasreducedhepatitisbvirustransmissioninthenetherlands
AT marijnvanballegooijen selectivehepatitisbvirusvaccinationhasreducedhepatitisbvirustransmissioninthenetherlands
AT jeroencremer selectivehepatitisbvirusvaccinationhasreducedhepatitisbvirustransmissioninthenetherlands
AT sylviabruisten selectivehepatitisbvirusvaccinationhasreducedhepatitisbvirustransmissioninthenetherlands
AT roelcoutinho selectivehepatitisbvirusvaccinationhasreducedhepatitisbvirustransmissioninthenetherlands
AT heinboot selectivehepatitisbvirusvaccinationhasreducedhepatitisbvirustransmissioninthenetherlands